HealthDecember 05, 2016

Webinar: Compounding with hazardous drugs: USP Chapter 800

USP 800 focuses on hazardous drugs in a healthcare setting. This webinar addresses its key areas of focus and how you can integrate it into your practice.

Proposed USP Chapter 800 sets a standard for handling hazardous drugs in healthcare settings. These drugs are not just limited to injectable oncology agents. They include oral, topical, inhalation, and injectable agents that are carcinogenic, teratogenic, cause reproductive toxicity in humans, cause organ toxicity at low doses in humans or animals, or are genotoxic.

Proposed Chapter 800 deals with methods to contain contamination from these agents, so is intended to promote safety among healthcare personnel in addition to the patient safety standards included in USP 795 and USP 797.

In this webinar, Patricia Kienle, RPh, MPA, FASHP reviews:

  • The key areas included in proposed Chapter 800
  • The elements you need to consider as you update your hazardous drug practices, training, and facilities

Access the on-demand webinar

Explore related topics
Solutions
Simplifi 797®

Take the guesswork out of USP medication compounding compliance with a customizable, mobile, evidence-based solution.

 

Simplifi 797 provides the latest evidence-based guidance and helps navigate the complex USP Chapters 795, 797 and 800 processes to ensure inspection confidence and keep patients and staff safe.